NO151088C - Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater - Google Patents

Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater

Info

Publication number
NO151088C
NO151088C NO79793993A NO793993A NO151088C NO 151088 C NO151088 C NO 151088C NO 79793993 A NO79793993 A NO 79793993A NO 793993 A NO793993 A NO 793993A NO 151088 C NO151088 C NO 151088C
Authority
NO
Norway
Prior art keywords
silyl
preparation
pharmacologically effective
glucosamine derivatives
analogy procedure
Prior art date
Application number
NO79793993A
Other languages
English (en)
Other versions
NO151088B (no
NO793993L (no
Inventor
Gerhard Baschang
Felix M Dietrich
Roland Gisler
Jaroslav Stanek
Albert Hartmann
Lajos Tarosay
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27173419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO151088(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO793993L publication Critical patent/NO793993L/no
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NO151088B publication Critical patent/NO151088B/no
Publication of NO151088C publication Critical patent/NO151088C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO79793993A 1978-02-24 1979-12-07 Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater NO151088C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH203578 1978-02-24
CH377778 1978-04-07
CH539478 1978-05-18

Publications (3)

Publication Number Publication Date
NO793993L NO793993L (no) 1979-08-27
NO151088B NO151088B (no) 1984-10-29
NO151088C true NO151088C (no) 1985-02-06

Family

ID=27173419

Family Applications (2)

Application Number Title Priority Date Filing Date
NO79790626A NO151201C (no) 1978-02-24 1979-02-23 Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO79793993A NO151088C (no) 1978-02-24 1979-12-07 Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO79790626A NO151201C (no) 1978-02-24 1979-02-23 Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater

Country Status (20)

Country Link
EP (1) EP0003833B2 (no)
JP (1) JPS54141718A (no)
AR (1) AR223833A1 (no)
AT (1) AT364718B (no)
AU (1) AU527549B2 (no)
CA (1) CA1138436A (no)
DD (1) DD141616A5 (no)
DK (1) DK161026C (no)
ES (2) ES477977A1 (no)
FI (1) FI66878C (no)
GB (1) GB2015534A (no)
GR (1) GR77615B (no)
HU (1) HU182011B (no)
IL (1) IL56724A (no)
NO (2) NO151201C (no)
NZ (1) NZ189756A (no)
PL (1) PL123315B1 (no)
PT (1) PT69281A (no)
SU (1) SU1055312A3 (no)
ZA (1) ZA79893B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130516A (en) * 1978-03-31 1979-10-09 Yuuichi Yamamura Acyllnnacetylmuramylpeptide derivativeeantigen combination
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
US4335111A (en) 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
US4406889A (en) 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4587046A (en) * 1982-05-18 1986-05-06 The Regents Of The University Of California Drug-carrier conjugates
FR2558165B1 (fr) * 1984-01-17 1986-07-04 Anvar Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
FR2569984B1 (fr) * 1984-09-12 1987-08-14 Anvar Molecule synthetique contenant une pluralite d'epitopes distincts, procede pour son obtention et application a la production de polyvaccins
AU2022239614A1 (en) 2021-03-19 2023-10-12 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH453269A4 (no) * 1968-03-29 1973-01-31
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
GB1573126A (en) * 1976-03-10 1980-08-13 Anvar Immunising and anti-infectious adjuvant agents comprising peptide derivatives of muramic acid
FR2343482A1 (fr) * 1976-03-10 1977-10-07 Anvar La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant

Also Published As

Publication number Publication date
NO151201B (no) 1984-11-19
FI66878B (fi) 1984-08-31
HU182011B (en) 1983-12-28
PT69281A (de) 1979-03-01
IL56724A0 (en) 1979-05-31
ATA142079A (de) 1981-04-15
NO151201C (no) 1985-02-27
PL213696A1 (no) 1980-07-14
FI66878C (fi) 1984-12-10
NO790626L (no) 1979-08-27
AU4454679A (en) 1979-08-30
NO151088B (no) 1984-10-29
FI790584A (fi) 1979-08-25
JPS54141718A (en) 1979-11-05
JPH0130809B2 (no) 1989-06-22
CA1138436A (en) 1982-12-28
EP0003833A2 (de) 1979-09-05
EP0003833A3 (en) 1980-02-06
GB2015534A (en) 1979-09-12
IL56724A (en) 1982-12-31
ZA79893B (en) 1980-03-26
DK161026C (da) 1991-10-28
ES477977A1 (es) 1980-01-16
AR223833A1 (es) 1981-09-30
PL123315B1 (en) 1982-10-30
AT364718B (de) 1981-11-10
SU1055312A3 (ru) 1983-11-15
NO793993L (no) 1979-08-27
EP0003833B2 (de) 1990-12-19
DK79779A (da) 1979-08-25
DD141616A5 (de) 1980-05-14
ES483558A1 (es) 1980-04-16
DK161026B (da) 1991-05-21
NZ189756A (en) 1982-05-31
GR77615B (no) 1984-09-25
AU527549B2 (en) 1983-03-10
EP0003833B1 (de) 1983-07-20

Similar Documents

Publication Publication Date Title
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO800626L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO791831L (no) Fremgangsmaate for fremstilling av aminotiazoler
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO151088C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO150155C (no) Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO148673C (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
DK350079A (da) Fremgangsmaade til fremstilling af indolinderivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO147310C (no) Fremgangsmaate for fremstilling av substituerte antitumorantracykliner